BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32297747)

  • 21. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
    Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
    EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ubiquitin ligase adaptor SPOP in cancer.
    Cuneo MJ; Mittag T
    FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activity.
    Usher ET; Sabri N; Rohac R; Boal AK; Mittag T; Showalter SA
    J Biol Chem; 2021; 296():100693. PubMed ID: 33894201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP).
    Zhou C; Hao X; Chen Z; Zhang R; Zhou Q; Fan Z; Zheng M; Hou H; Zhang S; Guo H
    ACS Med Chem Lett; 2024 Feb; 15(2):270-279. PubMed ID: 38352842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer.
    Zhi X; Tao J; Zhang L; Tao R; Ma L; Qin J
    Cell Death Dis; 2016 Dec; 7(12):e2569. PubMed ID: 28032859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
    Yan Y; Ma J; Wang D; Lin D; Pang X; Wang S; Zhao Y; Shi L; Xue H; Pan Y; Zhang J; Wahlestedt C; Giles FJ; Chen Y; Gleave ME; Collins CC; Ye D; Wang Y; Huang H
    EMBO Mol Med; 2019 Nov; 11(11):e10659. PubMed ID: 31559706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
    Dai X; Gan W; Li X; Wang S; Zhang W; Huang L; Liu S; Zhong Q; Guo J; Zhang J; Chen T; Shimizu K; Beca F; Blattner M; Vasudevan D; Buckley DL; Qi J; Buser L; Liu P; Inuzuka H; Beck AH; Wang L; Wild PJ; Garraway LA; Rubin MA; Barbieri CE; Wong KK; Muthuswamy SK; Huang J; Chen Y; Bradner JE; Wei W
    Nat Med; 2017 Sep; 23(9):1063-1071. PubMed ID: 28805820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical Characterization of the Binding Mechanism between the MATH Domain of SPOP and Its Physiological Partners.
    Diop A; Pietrangeli P; Nardella C; Pennacchietti V; Pagano L; Toto A; Di Felice M; Di Matteo S; Marcocci L; Malagrinò F; Gianni S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers.
    Certal V; Carry JC; Halley F; Virone-Oddos A; Thompson F; Filoche-Rommé B; El-Ahmad Y; Karlsson A; Charrier V; Delorme C; Rak A; Abecassis PY; Amara C; Vincent L; Bonnevaux H; Nicolas JP; Mathieu M; Bertrand T; Marquette JP; Michot N; Benard T; Perrin MA; Lemaitre O; Guerif S; Perron S; Monget S; Gruss-Leleu F; Doerflinger G; Guizani H; Brollo M; Delbarre L; Bertin L; Richepin P; Loyau V; Garcia-Echeverria C; Lengauer C; Schio L
    J Med Chem; 2014 Feb; 57(3):903-20. PubMed ID: 24387221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of speckled POZ protein, SPOP: putative regulation by miR-145.
    Huang CJ; Chen HY; Lin WY; Choo KB
    J Biosci; 2014 Jun; 39(3):401-13. PubMed ID: 24845504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitors.
    Dai X; Wang Z; Wei W
    Cell Cycle; 2017; 16(24):2326-2329. PubMed ID: 29108467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of 2'-substituted-4'-selenoribofuranosyl pyrimidines as antitumor agents.
    Alexander V; Song J; Yu J; Choi JH; Kim JH; Lee SK; Choi WJ; Jeong LS
    Arch Pharm Res; 2015 Jun; 38(6):966-72. PubMed ID: 25239109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
    Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
    Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BTB/POZ domain of speckle-type POZ protein (SPOP) confers proapoptotic function in HeLa cells.
    Byun B; Tak H; Joe CO
    Biofactors; 2007; 31(3-4):165-9. PubMed ID: 18997279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
    Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
    Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer.
    Gong DA; Zhou P; Chang WY; Yang JY; Zhang YL; Huang AL; Tang N; Wang K
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119642. PubMed ID: 37996058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
    Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
    PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF.
    Feng K; Shi Q; Jiao D; Chen Y; Yang W; Su K; Wang Y; Huang Y; Zhang P; Li Y; Wang C
    Cell Biosci; 2022 Dec; 12(1):211. PubMed ID: 36585710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.